Department of Immunology, Institute of General and Molecular Pathology, University of Tartu, Biomedicum, Estonia.
Am J Reprod Immunol. 2010 May;63(5):349-57. doi: 10.1111/j.1600-0897.2010.00808.x. Epub 2010 Feb 3.
Female infertility patients with diverse etiologies show increased production of autoantibodies.
Immunoblot analysis of sera from patients with endometriosis and tubal factor infertility (TFI) and mass spectrometry identification of candidate antigens.
The immunoblot results demonstrated the presence of IgA and IgG anti-endometrial antibodies (AEA) to various antigens at molecular weights ranging from 10 to 200 kDa. Differences were detected in certain AEA reactions between the patients' groups and particular AEA were associated with in vitro fertilization (IVF) implantation failure. IgA AEA to a 47-kDa protein were more prevalent in TFI patients and were associated with unsuccessful IVF treatment. This antigen was subsequently identified as alpha-enolase.
Determination of the presence and spectra of AEA in patients with endometriosis and TFI undergoing IVF may be a useful marker to predict their pregnancy outcome.
患有不同病因的女性不孕患者表现出自身抗体产生增加。
对子宫内膜异位症和输卵管因素不孕(TFI)患者的血清进行免疫印迹分析,并通过质谱鉴定候选抗原。
免疫印迹结果表明,在分子量为 10 至 200 kDa 的范围内,存在针对各种抗原的 IgA 和 IgG 抗子宫内膜抗体(AEA)。在患者组之间检测到某些 AEA 反应存在差异,某些 AEA 与体外受精(IVF)着床失败有关。TFI 患者中更常见的是针对 47 kDa 蛋白的 IgA AEA,并且与 IVF 治疗不成功相关。该抗原随后被鉴定为α-烯醇酶。
在接受 IVF 的子宫内膜异位症和 TFI 患者中确定 AEA 的存在和谱可能是预测其妊娠结局的有用标志物。